# Alpha-1-Antitrypsin-Deficiency in COVID-19

> **NCT04799873** · — · COMPLETED · sponsor: **Universität des Saarlandes** · enrollment: 10 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** AAT( Alpha 1 Antitrypsin)

## Key facts

- **NCT ID:** NCT04799873
- **Lead sponsor:** Universität des Saarlandes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-08
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04799873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04799873, "Alpha-1-Antitrypsin-Deficiency in COVID-19". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04799873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*